Literature DB >> 26003031

Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.

Stephan H Schirmer1, Marwa M Y A Sayed2, Jan-Christian Reil2, Daniel Lavall2, Christian Ukena2, Dominik Linz2, Felix Mahfoud2, Michael Böhm2.   

Abstract

OBJECTIVES: This study sought to investigate left atrial (LA) remodeling in relation to blood pressure (BP) and heart rate (HR) after renal sympathetic denervation (RDN).
BACKGROUND: In addition to reducing BP and HR in certain patients with hypertension, RDN can decrease left ventricular (LV) mass and ameliorate LV diastolic dysfunction.
METHODS: Before and 6 months after RDN, BP, HR, LV mass, left atrial volume index (LAVI), diastolic function (echocardiography), and premature atrial contractions (PAC) (Holter electrocardiogram) were assessed in 66 patients with resistant hypertension.
RESULTS: RDN reduced office BP by 21.6 ± 3.0/10.1 ± 2.0 mm Hg (p < 0.001), and HR by 8.0 ± 1.3 beats/min (p < 0.001). At baseline, LA size correlated with LV mass, diastolic function, and pro-brain natriuretic peptide, but not with BP or HR. Six months after RDN, LAVI was reduced by 4.0 ± 0.7 ml/kg/m(2) (p < 0.001). LA size decrease was stronger when LAVI at baseline was higher. In contrast, the decrease in LAVI was not dependent on LV mass or diastolic function (E/E' or E/A) at baseline. Furthermore, LAVI decreased without relation to decrease in systolic BP or HR. Additionally, occurrence of PAC (median of >153 PAC/24 h) was reduced (to 68 PAC/24 h) by RDN, independently of changes in LA size.
CONCLUSIONS: In patients with resistant hypertension, LA volume and occurrence of PAC decreased 6 months after RDN. This decrease was independent of BP and HR at baseline or the reduction in BP and HR reached by renal denervation. These data suggest that there is a direct, partly BP-independent effect of RDN on cardiac remodeling and occurrence of premature atrial contractions.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  echocardiography; left atrium; premature atrial contractions; renal denervation; resistant hypertension

Mesh:

Substances:

Year:  2015        PMID: 26003031     DOI: 10.1016/j.jcin.2015.02.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  12 in total

1.  Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Sebastian Ewen; Christian Ukena; Bodo Cremers; Carl-Martin Kirsch; Dirk Hellwig; Tareq Eweiwi; Samer Ezziddin; Murray Esler; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2015-10-22       Impact factor: 5.460

Review 2.  Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis.

Authors:  Dasheng Lu; Kai Wang; Qian Liu; Shengchan Wang; Qi Zhang; Qijun Shan
Journal:  Clin Res Cardiol       Date:  2016-02-02       Impact factor: 5.460

Review 3.  Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.

Authors:  Dominik Linz; Mathias Hohl; Adrian D Elliott; Dennis H Lau; Felix Mahfoud; Murray D Esler; Prashanthan Sanders; Michael Böhm
Journal:  Clin Auton Res       Date:  2018-02-10       Impact factor: 4.435

Review 4.  Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future.

Authors:  Bibhuti B Das
Journal:  Paediatr Drugs       Date:  2022-05-02       Impact factor: 3.022

5.  Renal Sympathetic Denervation in Rats Ameliorates Cardiac Dysfunction and Fibrosis Post-Myocardial Infarction Involving MicroRNAs.

Authors:  Xiaoxin Zheng; Xiaoyan Li; Yongnan Lyu; Yiyu He; Weiguo Wan; Xuejun Jiang
Journal:  Med Sci Monit       Date:  2016-08-04

Review 6.  Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale.

Authors:  Michael Böhm; Sebastian Ewen; Felix Mahfoud
Journal:  Korean Circ J       Date:  2016-12-02       Impact factor: 3.243

Review 7.  Heart failure with preserved ejection fraction based on aging and comorbidities.

Authors:  Ying Lin; Shihui Fu; Yao Yao; Yulong Li; Yali Zhao; Leiming Luo
Journal:  J Transl Med       Date:  2021-07-06       Impact factor: 5.531

Review 8.  Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future.

Authors:  Jan Wintrich; Ingrid Kindermann; Christian Ukena; Simina Selejan; Christian Werner; Christoph Maack; Ulrich Laufs; Carsten Tschöpe; Stefan D Anker; Carolyn S P Lam; Adriaan A Voors; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2020-03-31       Impact factor: 5.460

9.  Renal denervation in patients with symptomatic chronic heart failure despite resynchronization therapy - a pilot study.

Authors:  Tomasz Drożdż; Marek Jastrzębski; Paweł Moskal; Aleksander Kusiak; Agnieszka Bednarek; Katarzyna Styczkiewicz; Piotr Jankowski; Danuta Czarnecka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-06-26       Impact factor: 1.426

Review 10.  Extra-cardiac targets in the management of cardiometabolic disease: Device-based therapies.

Authors:  Ana Jorbenadze; Marat Fudim; Felix Mahfoud; Phillip B Adamson; Tarek Bekfani; Rolf Wachter; Horst Sievert; Piotr P Ponikowski; John G F Cleland; Stefan D Anker
Journal:  ESC Heart Fail       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.